Comparison of the protective efficacy of recombinant adenoviruses against classical swine fever

Immunology Letters

Volumn 135, Issue 1-2, 2011, Pages 43-49

  Sun, Yuan ^a   Li, Hong Yu ^a   Zhang, Xing Juan ^a   Chang, Tian Ming ^a   He, Fan ^a   Wang, Xiang Peng ^a   Liu, Da Fei ^a   Qiu, Hua Ji ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Classical swine fever virus; Comparison; Pig; Rabbit; Recombinant adenovirus

Indexed keywords

GAMMA INTERFERON; LIVE VACCINE; RECOMBINANT VACCINE; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CLASSICAL SWINE FEVER; CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; HUMORAL IMMUNITY; IMMUNOGENICITY; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS STRAIN;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; HERPESVIRUS 1, SUID; HUMANS; RABBITS; SWINE; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 78751701422     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.09.010     Document Type: Article

References (36)

1. Moennig V., Floegel-Niesmann G., Greiser-Wilke I. Clinical signs and epidemiology of classical swine fever: a review of new knowledge. Vet J 2003, 165:11-20.
2. Fauquet C.M., Mayo M.A., Maniloff J., Ball L.A. Virus taxonomy: VIIIth report of the international committee on taxonomy of viruses (ICTV) 2005, Elsevier Academic Press, Hong Kong.
3. Lindenbach B.D., Thiel H.J., Rice C.M. Flaviviridae: the viruses and their replication fields virology 2007, 1101-1157. Lippincott-Raven Publishers, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
4. van Rijn P.A., Bossers A., Wensvoort G., Moormann R.J. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J Gen Virol 1996, 77:2737-2745.
5. König M., Lengsfeld T., Pauly T., Stark R., Thiel H.J. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol 1995, 69:6479-6486.
6. Rümenapf T., Stark R., Meyers G., Thiel H.J. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J Virol 1991, 65:589-597.
7. van Zijl M., Wensvoort G., de Kluyver E., Hulst M., van der Gulden H., Gielkens A., et al. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol 1991, 65:2761-2765.
8. Hammond J.M., McCoy R.J., Jansen E.S., Morrissy C.J., Hodgson A.L., Johnson M.A. Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever. Vaccine 2000, 18:1040-1050.
9. Beer M., Reimann I., Hoffmann B., Depner K. Novel marker vaccines against classical swine fever. Vaccine 2007, 25(30):5665-5670.
10. Ganges L., Núñez J.I., Sobrino F., Borrego B., Fernández-Borges N., Frías-Lepoureau M.T., et al. Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection. Vet J 2008, 177(2):169-177.
11. Lin G.J., Liu T.Y., Tseng Y.Y., Chen Z.W., You C.C., Hsuan S.L., et al. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response. Vet Microbiol 2009, 139(3-4):369-374.
12. Sánchez O., Barrera M., Rodríguez M.P., Frías M.T., Figueroa N.E., Naranjo P., et al. Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge. Vaccine 2008, 26(7):988-997.
13. Eloit M. Defective adenoviruses as virus vectors for veterinary vaccines. Vet Res 1995, 26(3):207-208.
14. Imler J.L. Adenovirus vectors as recombinant viral vaccines. Vaccine 1995, 13:1143-1151.
15. Berdichevsky M., Gentile M.P., Hughes B., Meis P., Peltier J., Blumentals I., et al. Establishment of higher passage PER.C6 cells for adenovirus manufacture. Biotechnol Prog 2008, 24:158-165.
16. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997, 88:223-233.
17. Zhao H.P., Sun J.F., Li N., Sun Y., Wang Y., Qiu H.J. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice. Vet Immunol Immunopathol 2009, 131:158-166.
18. Jiang Y., Yu K., Zhang H., Zhang P., Li C., Tian G., et al. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antiviral Res 2007, 75:234-241.
19. Lim L.H., Li H.Y., Cheong N., Lee B.W., Chua K.Y. High-level expression of a codon optimized recombinant dust mite allergen, Blo t 5, in Chinese hamster ovary cells. Biochem Biophys Res Commun 2004, 316:991-996.
20. Gaucher D., Chadee K. Construction and immunogenicity of a codon-optimized Entamoeba histolytica Gal-lectin-based DNA vaccine. Vaccine 2002, 20:3244-3253.
21. Bradel-Tretheway B.G., Zhen Z., Dewhurst S. Effects of codon-optimization on protein expression by the human herpesvirus 6 and 7 U51 open reading frame. J Virol Methods 2003, 111:145-156.
22. Burgess-Brown N.A., Sharma S., Sobott F., Loenarz C., Oppermann U., Gileadi O. Codon optimization can improve expression of human genes in Escherichia coli: a multi-gene study. Protein Expr Purif 2008, 59:94-102.
23. Sun Y., Liu D.F., Wang Y.F., Liang B.B., Cheng D., Li N., et al. Generation and efficacy evaluation of a recombinant adenovirus expressing the E2 protein of classical swine fever virus. Res Vet Sci 2010, 88:77-82.
24. Benihoud K., Yeh P., Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999, 10:440-447.
25. Zhao J.J., Cheng D., Li N., Sun Y., Shi Z., Zhu Q.H., et al. Evaluation of a multiplex real-time RT-PCR for quantitative and differential detection of wild-type viruses and C-strain vaccine of classical swine fever virus. Vet Microbiol 2008, 126:1-10.
26. Peng W.P., Hou Q., Xia Z.H., Chen D., Li N., Sun Y., et al. Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of classical swine fever virus by phage-displayed random peptide library. Virus Res 2008, 135:267-272.
27. Müller T., Depner K.R., Burow J., Ahl R., Conraths F.J., Moennig V. Comparison of different BVD virus strains for their use in the differential diagnosis of classical swine fever-an attempt to standardize neutralization tests. Dtsch Tierarztl Wochenschr 1997, 104:91-96.
28. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 2002, 415:331-335.
29. Sharpe S., Fooks A., Lee J., Hayes K., Clegg C., Cranage M. Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses. Virology 2002, 293:210-216.
30. Lemiale F., Kong W.P., Akyürek L.M., Ling X., Huang Y., Chakrabarti B.K., et al. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J Virol 2003, 77:10078-10087.
31. Terpstra C., Wensvoort G. The protective value of vaccine-induced neutralising antibody titres in swine fever. Vet Microbiol 1988, 16:123-128.
32. Peeters B., Bienkowska-Szewczyk K., Hulst M., Gielkens A., Kimman T. Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever. J Gen Virol 1997, 78:3311-3315.
33. Cote-Sierra J., Foucras G., Guo L., Chiodetti L., Young H.A., Hu-Li J., et al. Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A 2004, 101:3880-3885.
34. Tarradas J., Argilaguet J.M., Rosell R., Nofrarías M., Crisci E., Córdoba L., et al. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs. Vet Microbiol 2010, 142:51-58.
35. Russell M.S., Dudani R., Krishnan L., Sad S. IFN-gamma expressed by T cells regulates the persistence of antigen presentation by limiting the survival of dendritic cells. J Immunol 2009, 183:77-108.
36. Tokuoka M., Tanaka M., Ono K., Takagi S., Shintani T., Gomi K. Codon optimization increases steady-state mRNA levels in Aspergillus oryzae heterologous gene expression. Appl Environ Microbiol 2008, 74:6538-6546.